Accustem Sciences ACUT
OTC ACUT
$0.22 -0.02 (-8.33%)
At close: Aug 19, 2026 · 4:00 PM EDT

Accustem Sciences (ACUT) EPS (Basic) Growth (5y) (2026)

Accustem Sciences (ACUT) EPS (Basic) Growth (5y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.83 Bn 130.98 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.79 Bn 77.79 Bn 3.93 Bn
3 Argenx Se 64.95 Bn 59.77 Bn 1.37 Bn
4 Moderna 58.59 Bn 53.46 Bn 52.00 Mn
5 BeOne Medicines 41.93 Bn 36.83 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.52 Bn 28.21 Bn 992.69 Mn
7 BioNTech SE 27.98 Bn 9.58 Bn 668.28 Mn
8 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
9 Royalty Pharma 27.33 Bn 26.49 Bn -
10 Accustem Sciences 2.57 Mn 2.56 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -85.20%